Over the last 30 years, the CCPA has provided alternative research and analysis that have been indispensable in exposing the corporate agenda. I don’t know what I’d have done without them.
— Judy Rebick
National Office | Update
September 13, 2010
The main argument that is typically made against the establishment of universal Pharmacare is economic in nature. However, a new CCPA report shows that the economic argument in favour of such a program is loud and clear, regardless of which industrial policy is subsequently considered. Canadians could save between 10% and 42%—up to $10.7 billion—of total drug expenditures.